NASDAQ:LPCN

Lipocine Stock News

Healthcare > Biotechnology

Buy LPCN

*Your capital is at risk

$2.19

-0.0600 (-2.67%)

At Close: Jun 03, 2026

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ...

12:00am, Wednesday, 04'th Dec 2019

INVESTOR ALERT - Lipocine Inc. (LPCN) - Bronstein, Gewirtz & Grossman, LLC Notifies ...

12:00am, Friday, 29'th Nov 2019

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ...

12:00am, Wednesday, 27'th Nov 2019

Lipocine 13G Filing From Sabby Shows New 8.74% Stake

12:00am, Friday, 22'nd Nov 2019

LPCN LOSS NOTICE: ROSEN, A GLOBAL LAW FIRM, Announces Filing of Securities Class Action Lawsuit ...

12:00am, Thursday, 21'st Nov 2019

The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down

12:00am, Sunday, 17'th Nov 2019

70 Biggest Movers From Yesterday

12:00am, Friday, 15'th Nov 2019

Lipocine Prices Offering Of 10.45M Class A Units And 1.55M Class B Units At $0.50/Class A Unit And $0.4999/Class B Unit

12:00am, Thursday, 14'th Nov 2019

Lipocine shares are trading lower after the company reported a common stock offering of no disclosed size.

12:00am, Wednesday, 13'th Nov 2019

Lipocine Q3 EPS $(0.12), Same YoY

12:00am, Tuesday, 12'th Nov 2019

Mid-Afternoon Market Update: Qurate Retail Gains On Upbeat Earnings; ASLAN Pharmaceuticals Shares Slide

07:45pm, Monday, 11'th Nov 2019

38 Stocks Moving In Monday's Mid-Day Session

05:10pm, Monday, 11'th Nov 2019

Mid-Day Market Update: Carbonite Jumps Following Acquisition News; Lipocine Shares Plummet

05:00pm, Monday, 11'th Nov 2019

Lipocine Stock News

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ...

INVESTOR ALERT - Lipocine Inc. (LPCN) - Bronstein, Gewirtz & Grossman, LLC Notifies ...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ...

Lipocine 13G Filing From Sabby Shows New 8.74% Stake

LPCN LOSS NOTICE: ROSEN, A GLOBAL LAW FIRM, Announces Filing of Securities Class Action Lawsuit ...

The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down

70 Biggest Movers From Yesterday

Lipocine Prices Offering Of 10.45M Class A Units And 1.55M Class B Units At $0.50/Class A Unit And $0.4999/Class B Unit

Lipocine shares are trading lower after the company reported a common stock offering of no disclosed size.

Lipocine Q3 EPS $(0.12), Same YoY

Mid-Afternoon Market Update: Qurate Retail Gains On Upbeat Earnings; ASLAN Pharmaceuticals Shares Slide

38 Stocks Moving In Monday's Mid-Day Session

Mid-Day Market Update: Carbonite Jumps Following Acquisition News; Lipocine Shares Plummet

Mid-Morning Market Update: Markets Open Lower; SunPower To Receive $298 Million Equity In Company Split

Lipocine's Male Hormone Therapy Stumbles With FDA For The Third Time

Top Fintech Company